Effect of Anthocyanins Supplementation on Serum IGFBP-4 Fragments and Glycemic Control in Patients with Fasting Hyperglycemia: A Randomized Controlled Trial

References

• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151
   PubMed Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Fowlkes J, Freemark M. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. Endocrinology. 1992;131(5):2071–2076. doi:10.1210/endo.131.5.1385096
   PubMedGoogle Scholar
• Bach LA. Insulin-like growth factor binding proteins 4-6. Best Pract Res Clin Endocrinol Metab. 2015;29(5):713–722. doi:10.1016/j.beem.2015.06.002
   PubMedGoogle Scholar
• Mazerbourg S, Callebaut I, Zapf J, Mohan S, Overgaard M, Monget P. Up date on IGFBP-4: regulation of IGFBP-4 levels and functions, in vitro and in vivo. Growth Hormone IGF Res. 2004;14(2):71–84. doi:10.1016/j.ghir.2003.10.002
   PubMedGoogle Scholar
• Lewitt MS, Dent MS, Hall K. The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus. J Clin Med. 2014;3(4):1561–1574. doi:10.3390/jcm3041561
   PubMedGoogle Scholar
• de Kort S, Simons C, van den Brandt PA, et al. Diabetes mellitus, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk. Int J Cancer. 2019. doi:10.1002/ijc.32365
   PubMedGoogle Scholar
• Hjortebjerg R, Laugesen E, Hoyem P, et al. The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage. Eur j Endocrinol. 2017;176(5):521–531. doi:10.1530/EJE-16-0940
   PubMedGoogle Scholar
• Curtis PJ, van der Velpen V, Berends L, et al. Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome-results from a 6-month, double-blind, randomized controlled trial. Am J Clin Nutr. 2019;109(6):1535–1545. doi:10.1093/ajcn/nqy380
   PubMedGoogle Scholar
• Mirfeizi M, Mehdizadeh Tourzani Z, Mirfeizi SZ, Asghari Jafarabadi M, Rezvani HR, Afzali M. Controlling type 2 diabetes mellitus with herbal medicines: A triple-blind randomized clinical trial of efficacy and safety. J Diabetes. 2016;8(5):647–656. doi:10.1111/1753-0407.12342
   PubMedGoogle Scholar
• Yang L, Ling W, Yang Y, et al. Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes-A Randomized Controlled Trial. Nutrients. 2017;9.
   Google Scholar
• Tripathy D, Carlsson M, Almgren P, et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes. 2000;49(6):975–980. doi:10.2337/diabetes.49.6.975
   PubMed Web of Science ®Google Scholar
• Hanefeld M, Koehler C, Fuecker K, et al. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care. 2003;26(3):868–874. doi:10.2337/diacare.26.3.868
   PubMed Web of Science ®Google Scholar
• American Diabetes A. Standards of medical care in diabetes–2013. Diabetes Care. 2013;36(Suppl 1):S11–S66.
   PubMedGoogle Scholar
• Zhu Y, Ling W, Guo H, et al. Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: a randomized controlled trial. Nutr Metab Cardiovasc Dis. 2013;23:843–849. doi:10.1016/j.numecd.2012.06.005
   PubMed Web of Science ®Google Scholar
• Zhu Y, Xia M, Yang Y, et al. Purified anthocyanin supplementation improves endothelial function via NO-cGMP activation in hypercholesterolemic individuals. Clin Chem. 2011;57(11):1524–1533. doi:10.1373/clinchem.2011.167361
   PubMed Web of Science ®Google Scholar
• Qin Y, Xia M, Ma J, et al. Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am J Clin Nutr. 2009;90(3):485–492. doi:10.3945/ajcn.2009.27814
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Burattini R, Di Nardoa F, Casagrande F, Boemi M, Morosini P. Insulin action and secretion in hypertension in the absence of metabolic syndrome: model-based assessment from oral glucose tolerance test. Metabo Clin Exp. 2009;58(1):80–92. doi:10.1016/j.metabol.2008.08.010
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 2006;55(5):1430–1435. doi:10.2337/db05-1200
   PubMed Web of Science ®Google Scholar
• Okuno Y, Komada H, Sakaguchi K, et al. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes. Metabolism. 2013;62(10):1470–1476. doi:10.1016/j.metabol.2013.05.022
   PubMedGoogle Scholar
• Conover CA. Key questions and answers about pregnancy-associated plasma protein-A. Trends Endocrinol Metab. 2012;23(5):242–249. doi:10.1016/j.tem.2012.02.008
   PubMedGoogle Scholar
• Conover CA, Bale LK, Oxvig C. Targeted Inhibition of Pregnancy-Associated Plasma Protein-A Activity Reduces Atherosclerotic Plaque Burden in Mice. J Cardiovasc Transl Res. 2016;9(1):77–79. doi:10.1007/s12265-015-9666-9
   PubMedGoogle Scholar
• Sitar T, Popowicz GM, Siwanowicz I, Huber R, Holak TA. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc Natl Acad Sci U S A. 2006;103(35):13028–13033. doi:10.1073/pnas.0605652103
   PubMedGoogle Scholar
• Resch ZT, Simari RD, Conover CA. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury. Endocrinology. 2006;147(12):5634–5640. doi:10.1210/en.2006-0493
   PubMedGoogle Scholar
• Byun D, Mohan S, Yoo M, Sexton C, Baylink DJ, Qin X. Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro. J Clin Endocrinol Metab. 2001;86(2):847–854. doi:10.1210/jcem.86.2.7223
   PubMedGoogle Scholar
• Aleidi SM, Shayeb E, Bzour J, et al. Serum level of insulin-like growth factor-I in type 2 diabetic patients: impact of obesity. Horm Mol Biol Clin Investig. 2019;39.
   Google Scholar
• Miyake H, Kanazawa I, Sugimoto T. Decreased serum insulin-like growth factor-I level is associated with the increased mortality in type 2 diabetes mellitus. Endocr J. 2016;63(9):811–818. doi:10.1507/endocrj.EJ16-0076
   PubMed Web of Science ®Google Scholar
• Ruidavets JB, Luc G, Machez E, et al. Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: the PRIME study. Atherosclerosis. 2011;218(2):464–469. doi:10.1016/j.atherosclerosis.2011.05.034
   PubMedGoogle Scholar
• van Bunderen CC, van Nieuwpoort IC, van Schoor NM, Deeg DJ, Lips P, Drent ML. The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study. J Clin Endocrinol Metab. 2010;95(10):4616–4624. doi:10.1210/jc.2010-0940
   PubMedGoogle Scholar
• Schneider HJ, Klotsche J, Saller B, et al. Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients. Eur j Endocrinol. 2008;158(2):153–161. doi:10.1530/EJE-07-0600
   PubMedGoogle Scholar
• Maximus PS. Insulin like growth factor 1 is linked to higher cardiovascular risk score in adults with type 2 diabetes mellitus and chronic kidney disease. Diabetes Metab Syndr. 2019;13(4):2613–2618. doi:10.1016/j.dsx.2019.07.008
   PubMedGoogle Scholar
• Postnikov AB, Smolyanova TI, Kharitonov AV, et al. N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia. Clin Biochem. 2012;45(7–8):519–524. doi:10.1016/j.clinbiochem.2011.12.030
   PubMedGoogle Scholar
• Fierro-Macias AE, Floriano-Sanchez E, Mena-Burciaga VM, et al. Association between IGF system and PAPP-A in coronary atherosclerosis. Arch Cardiol Mex. 2016;86(2):148–156. doi:10.1016/j.acmx.2015.12.006
   PubMedGoogle Scholar
• Bayes-Genis A, Conover CA, Schwartz RS. The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ Res. 2000;86(2):125–130. doi:10.1161/01.RES.86.2.125
   PubMedGoogle Scholar
• Rajpathak SN, He M, Sun Q, et al. Insulin-like growth factor axis and risk of type 2 diabetes in women. Diabetes. 2012;61(9):2248–2254. doi:10.2337/db11-1488
   PubMedGoogle Scholar
• Fan D, Alamri Y, Liu K, et al. Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: potential Treatment to Improve Insulin-Like Growth Factor-1 Function. Nutrients. 2018;10.
   PubMedGoogle Scholar
• Imrie H, Abbas A, Viswambharan H, et al. Vascular insulin-like growth factor-I resistance and diet-induced obesity. Endocrinology. 2009;150(10):4575–4582. doi:10.1210/en.2008-1641
   PubMed Web of Science ®Google Scholar
• Edirisinghe I, Burton-Freeman B, Seeram NP, Shukkitt-Hale B. Anti-diabetic actions of Berry polyphenols – review on proposed mechanisms of action. J Berry Res. 2016;6:237–250. doi:10.3233/JBR-160137
   Web of Science ®Google Scholar
• Yang L, Ling W, Du Z, et al. Effects of Anthocyanins on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr. 2017;8(5):684–693. doi:10.3945/an.116.014852
   PubMed Web of Science ®Google Scholar
• Fallah AA, Sarmast E, Jafari T. Effect of dietary anthocyanins on biomarkers of glycemic control and glucose metabolism: A systematic review and meta-analysis of randomized clinical trials. Food Res Int. 2020;137:109379. doi:10.1016/j.foodres.2020.109379
   PubMed Web of Science ®Google Scholar
• Jacot TA, Clemmons DR. Effect of Glucose on Insulin-Like Growth Factor Binding Protein-4 Proteolysis 1. Endocrinology. 1998;139(1):44–50. doi:10.1210/endo.139.1.5688
   PubMedGoogle Scholar
• Boulware SD, Tamborlane WV, Rennert NJ, Gesundheit N, Sherwin RS. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults. J Clin Invest. 1994;93(3):1131–1139. doi:10.1172/JCI117065
   PubMed Web of Science ®Google Scholar
• Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41(3):368–377. doi:10.2337/diabetes.41.3.368
   PubMed Web of Science ®Google Scholar
• Utzschneider KM, Prigeon RL, Tong J, et al. Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies. Diabetologia. 2007;50(12):2516–2525. doi:10.1007/s00125-007-0819-5
   PubMed Web of Science ®Google Scholar
• Grunberger G, Qiang X, Li Z, et al. Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia. 2001;44(10):1247–1257. doi:10.1007/s001250100632
   PubMed Web of Science ®Google Scholar
• Anoop S, Misra A, Bhatt SP, Gulati S, Mahajan H. High fasting C-peptide levels and insulin resistance in non-lean & non-obese (BMI >19 to < 25kg/m(2)) Asian Indians with type 2 diabetes are independently associated with high intra-abdominal fat and liver span. Diabetes Metab Syndr. 2019;13:708–715.
   PubMed Web of Science ®Google Scholar
• Liu M, Ao L, Hu X, et al. Influence of blood glucose fluctuation, C-peptide level and conventional risk factors on carotid artery intima-media thickness in Chinese Han patients with type 2 diabetes mellitus. Eur J Med Res. 2019;24(1):13. doi:10.1186/s40001-019-0370-0
   PubMedGoogle Scholar
• Pikkemaat M, Andersson T, Melander O, Chalmers J, Radholm K, Bengtsson Bostrom K. C-peptide predicts all-cause and cardiovascular death in a cohort of individuals with newly diagnosed type 2 diabetes. Skaraborg Diabetes Reg Diabetes Res Clin Pract. 2019;150:174–183. doi:10.1016/j.diabres.2019.03.014
   PubMedGoogle Scholar
• Kim JD, Kang SJ, Lee MK, et al. C-Peptide-Based Index Is More Related to Incident Type 2 Diabetes in Non-Diabetic Subjects than Insulin-Based Index. Endocrinol Metab. 2016;31(2):320–327. doi:10.3803/EnM.2016.31.2.320
   Google Scholar
• Postprandial SY. C-Peptide to Glucose Ratio as a Marker of beta Cell Function: implication for the Management of Type 2 Diabetes. Int J Mol Sci. 2016;17.
   PubMedGoogle Scholar
• Meier JJ, Menge BA, Breuer TG, et al. Functional assessment of pancreatic beta-cell area in humans. Diabetes. 2009;58(7):1595–1603. doi:10.2337/db08-1611
   PubMedGoogle Scholar
• Binoux M. The IGF system in metabolism regulation. Diabete Metab. 1995;21:330–337.
   PubMed Web of Science ®Google Scholar
• Wittfooth S, Qin QP, Lund J, et al. Immunofluorometric point-of-care assays for the detection of acute coronary syndrome-related noncomplexed pregnancy-associated plasma protein A. Clin Chem. 2006;52(9):1794–1801. doi:10.1373/clinchem.2006.070607
   PubMedGoogle Scholar
• Hjortebjerg R. IGFBP-4 and PAPP-A in normal physiology and disease. Growth Hormone IGF Res. 2018;41:7–22. doi:10.1016/j.ghir.2018.05.002
   PubMed Web of Science ®Google Scholar